More specifically, in our previous study for a cutoff value of 10.51 ng/ml, serum S100B on the 1st day of life performed an excellent sensitivity of 100% and specificity of 93.9% to predict severe adverse neonatal outcome such as death or IVH of II-V grade complicated with seizures and/or hypertonia. This evidence concerns the gene S100B and Hypertonia.